Sinovac Hong Kong executive says trials for Omicron jab may start this month, global distribution in May

Chinese vaccine maker Sinovac Biotech has revealed that it plans to begin clinical trials for a jab to treat the highly transmissible Omicron variant this month, and hopes to begin global distribution by May.Meng Weining, vice-president of Sinovac (Hong Kong) Biotech, one of the two manufacturers supplying Covid-19 jabs to the city, said in an interview on Thursday that ongoing animal trials had shown promising results after the firm obtained Omicron samples from the local government and the…

Read the original article at South China Morning Post